Microvascular Therapeutics Finalizes Facility Certification for the Production of MVT-100.

Recent Posts

Salt Lake City, UT – July 13, 2025 – Microvascular Therapeutics (MVT), a pioneering Utah based biotechnology company, is thrilled to...

Boston, MA – June 18, 2025 – Microvascular Therapeutics (MVT) is pleased to announce Founder and CEO, Dr. Evan Unger, as speaker on the...

May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...